Mayer LS, Arnold J, Roettele F, Reuter N, Pattekar A, Ohtani T, Ribeiro MM, Siwicki R, Bruder K, Obwegs D, Stahl E, Buechel S, Roehlen N, Kolter J, Mansoori Moghadam Z, Alaswad A, Zhumalidova Z, Li G, Liu X, Li Y, Singh A, Villacorta Hidalgo J, Paraskevopoulou MD, Yajnik V, Juarez J, Ren Y, Li H, Wherry EJ, Lewis JD, Wu GD, Bewtra M, Tomov VT, Thimme R, Bengsch B, Hasselblatt P, Picelli S, Hofmann M, Sagar. Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitis , Sci Immunol, 11: 2026,eadx8474
Karakasheva TA, Martinez CM, Zhou Y, Qui J, Chen XE, Soto GE, Nettleford SK, Hix OT, Roach DM, Laguerta AM, Thadi A, Edwards RM, Aleynick D, Weinbrom S, Borodyanskaya E, Pickering OH, Fulton M, Chen CH, Peterson IV, Hagen EB, Yannuzzi IP, Haider Z, Cramer Z, Conrad MA, Li N, Bewtra M, Uzun Y, Tan K, Kelsen JR, Minn AJ, Lengner CJ, Hamilton KE. An Epigenetic Basis for Sustained Inflammatory Epithelial Progenitor Cell States in Crohn's Disease , Cell Mol Gastroenterol Hepatol, 20: 2025,101665
Mayer AS, Xiao R, Grossman A, Bewtra M, George MD, Weiss PF. Temporal Trends in and Associations With Nonsteroidal Anti-inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease , Arthritis Care Res (Hoboken): 2025
Yang H, Dungan M, Beyries K, Wang X, Kilpatrick R, Chen B, Oh S, Berkowitz M, Smith D, Koralov SB, Axelrad J, Lengner CJ, Belle N, Bewtra M, Katona BW, Cadwell K. MAIT cell enrichment in Lynch syndrome is associated with immune surveillance and colorectal cancer risk , bioRxiv: 2025
Cao S, Nguyen KM, Ma K, Tan T, Yao X, Liu TC, Ayoub M, Devi J, Samaan S, Liu Y, Smith R, Silviera ML, Hunt SR, Wise PE, Mutch MG, Glasgow SC, Chapman WC Jr, Cowan ML, Ciorba MA, Colonna M, Deepak P; SPARC IBD Investigators. Revealing hyperactivated IFN-γ pathways in perianal fistulizing Crohn's disease using single-cell and spatial multi-omics , J Clin Invest, 135: 2025,e193413
Bewtra, Meenakshi; Schreiber, Stefan; Buisson, Anthony; Hur, Peter; Panattoni, Laura; Hauber, Brett; Gahlon, Grace; Coulter, Josh; Smith, Christina; Guo, Xiang; Land, Natalie; Wosik, Karolina; Cappelleri, Joseph; Maravic, Melissa Culhane; Walsh, Alissa Comparing the benefit-risk tradeoffs advanced therapy naïve vs experienced patients are willing to accept when selecting advanced therapy for moderate-to-severe ulcerative colitis: A discrete choice experiment in the United States and Europe , Digestive Disease Week, San Diego CA: 2025
Regueiro MD, Bewtra M, Dubinsky MC, Branquinho D, Feng C, McDonnell A, Gianfrancesco MA. Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States , Inflamm Bowel Dis: 2025
Kruger AJ, Dormont F, Capit N, Schilsky S, Roberts A, Lin Y, Badalamenti S, Wiekowski M, Bewtra M, Colombel JF. Biologic Switch Timing and Risk of Infection in Patients With Ulcerative Colitis/Crohn's Disease: A Retrospective Study , Clin Gastroenterol Hepatol: 2025
Bewtra M "Attacks on Science" , Stand Up For Science, Philadelphia Rally: 2025
Yang JC, Janssen EM, Wallace MJ, Sheahan A, Lynch J, Bewtra M, Marko M, Johnson FR, Bozzi LM. Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease , Am J Gastroenterol, 120: 2025,2848-2856
